Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.57B |
| 2 |
PNC Financial Services
PNC
|
+$1.29B |
| 3 |
Chevron
CVX
|
+$1.27B |
| 4 |
Vale
VALE
|
+$1.12B |
| 5 |
Citigroup
C
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.67B |
| 2 |
Corpay
CPAY
|
+$1.54B |
| 3 |
ExxonMobil
XOM
|
+$1.04B |
| 4 |
Constellation Brands
STZ
|
+$967M |
| 5 |
Dominion Energy
D
|
+$888M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.84% |
| 2 | Healthcare | 16.81% |
| 3 | Communication Services | 14.24% |
| 4 | Consumer Discretionary | 13.1% |
| 5 | Financials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
SiriusPoint
SPNT
$2.66B
| $22.2M | 0.01% |
+2,336,075
| New | +$20.4M |
|
377
Hilltop Holdings
HTH
$2.25B
| $20.6M | 0.01% |
750,000
| – | – |
|
|
NCNA
378
NuCana
NCNA
$5.95M
| $20.6M | 0.01% |
916
| – | – |
|
379
Graham Holdings Company
GHC
$5.03B
| $18.1M | ﹤0.01% |
34,000
| – | – |
|
|
JAMF
380
DELISTED
Jamf
JAMF
| $16.7M | ﹤0.01% |
559,015
-158,900
| -22% | -$5.24M |
|
381
Pulmonx
LUNG
$98.4M
| $15.5M | ﹤0.01% |
+225,000
| New | +$11M |
|
382
LiveRamp
RAMP
$2.3B
| $15M | ﹤0.01% |
+204,300
| New | +$13M |
|
383
Cardlytics
CDLX
$24.7M
| $14.3M | ﹤0.01% |
10,000
| – | – |
|
384
StepStone Group
STEP
$3.96B
| $11.7M | ﹤0.01% |
294,100
+17,244
| +6% | +$500K |
|
|
AIFU
385
AIFU Inc
AIFU
$218M
| $11.1M | ﹤0.01% |
2,300
-1,140
| -33% | -$6.71M |
|
386
Qualcomm
QCOM
$171B
| $10.4M | ﹤0.01% |
68,036
-739,635
| -92% | -$103M |
|
387
Curtiss-Wright
CW
$26.7B
| $9.25M | ﹤0.01% |
79,500
-270,484
| -77% | -$28.5M |
|
|
HUIZ
388
Huize Holding Ltd
HUIZ
$12.7M
| $7.35M | ﹤0.01% |
210,000
| – | – |
|
|
AMED
389
DELISTED
Amedisys
AMED
| $5.04M | ﹤0.01% |
17,200
| – | – |
|
390
ASML
ASML
$695B
| $3.77M | ﹤0.01% |
7,697
-7,952
| -51% | -$3.35M |
|
391
Ares Management
ARES
$32.1B
| $2.15M | ﹤0.01% |
45,670
| – | – |
|
392
Barclays
BCS
$94.4B
| $1.88M | ﹤0.01% |
233,475
+37,400
| +19% | +$250K |
|
393
Takeda Pharmaceutical
TAK
$55.6B
| $1.19M | ﹤0.01% |
65,430
+10,055
| +18% | +$176K |
|
394
STMicroelectronics
STM
$48.4B
| $1.17M | ﹤0.01% |
31,150
+4,521
| +17% | +$160K |
|
395
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $642K | ﹤0.01% |
1,725
+1,101
| +176% | +$391K |
|
396
Alcoa
AA
$13.5B
| $640K | ﹤0.01% |
27,753
| – | – |
|
397
Fresenius Medical Care
FMS
$12.6B
| $627K | ﹤0.01% |
15,096
+2,311
| +18% | +$96.3K |
|
398
TSMC
TSM
$2.23T
| $480K | ﹤0.01% |
4,411
+576
| +15% | +$54.6K |
|
|
AIG.WS
399
DELISTED
American International Group, Inc.
AIG.WS
| $378K | ﹤0.01% |
3,152,474
| – | – |
|
400
Equifax
EFX
$21.2B
| $294K | ﹤0.01% |
1,536
-806,861
| -100% | -$136M |
|
Similar funds
Capital Research Global Investors's Q4 2020 Portfolio in Review
As of Q4 2020, Capital Research Global Investors held 437 positions worth $385B, up 16% from $333B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Research Global Investors's Q4 2020 filing shows 32 new, 206 increased, 119 reduced and 33 closed positions. Its largest new stake was Airbnb: 4,855,453 shares worth $713M. The largest sale was Meta Platforms (Facebook), an estimated $1.67B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Communication Services.
- Capital Research Global Investors's largest Q4 2020 buy was Airbnb: 4,855,453 shares worth $713M.
- Capital Research Global Investors added most to JPMorgan Chase in Q4 2020, an estimated $1.57B increase.
- Capital Research Global Investors's biggest Q4 2020 reduction was Meta Platforms (Facebook), cutting an estimated $1.67B.
- Capital Research Global Investors fully exited Vertex Pharmaceuticals in Q4 2020, selling an estimated $340M.
- Capital Research Global Investors's ten largest holdings make up 30% of its $385B portfolio in Q4 2020.
- Capital Research Global Investors opened 32 new positions and closed 33 in Q4 2020.
- Capital Research Global Investors's portfolio value rose 16% quarter-over-quarter to $385B.
Based on Capital Research Global Investors's 13F filing for Q4 2020, filed 12 Feb 2021.